Skip to content

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

Type 1 Diabetes Data Acquisition and Transfer Adherence Study

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03228004
Acronym
T1D-DATA
Enrollment
53
Registered
2017-07-24
Start date
2017-07-26
Completion date
2019-04-08
Last updated
2019-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitus

Brief summary

The purpose of this pilot study is to determine if training and support, combined with reminders to facilitate glucose data sharing with the diabetes care team in between clinic visits, can improve glycemic outcomes for patients ages 10-17 with type 1 diabetes who have HbA1c levels above target.

Interventions

BEHAVIORALGlooko MeterSync

The participant and caregiver will receive a reminder via text or email to upload glucose data via Glooko on a biweekly basis.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis with T1D at least 6 months before consent is obtained * Aged ≥ 2 years and ≤17 years at time of enrollment * Must have access to a smartphone, tablet or computer at home with wireless connectivity * Last HbA1c of ≥7.6% and ≤11% * Using fixed doses, multiple daily injections or an insulin pump as primary diabetes management regimen * Ability to read and speak English * Patient at UF Health Pediatric Diabetes Clinic

Exclusion criteria

* Significant medical comorbidity in the child or adolescent that could, in the opinion of the PI, affect participant's capacity to complete study follow up * Inability to read and speak English * Not using insulin therapy * Lack of access to mobile device or computer with wireless internet connectivity * Unwilling or unable to use clinic's software (Glooko) to facilitate glucose data upload

Design outcomes

Primary

MeasureTime frameDescription
Improved glycemic control16 weeksHbA1c
Frequency of data upload16 weeksThe number of times glucose data is uploaded between clinic visits

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026